Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Suzanne Einmahl"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 226-236 (2024)
ABSTRACTIntroduction Tick-borne encephalitis (TBE) is rapidly spreading to new areas in many parts of Europe. While vaccination remains the most effective method of protection against the disease, vaccine uptake is low in many endemic countries.Areas
Externí odkaz:
https://doaj.org/article/76f4bf30ae3341938b9f49774695c6ad
Publikováno v:
CHIMIA, Vol 55, Iss 3 (2001)
Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been under development since the early 1970s. Up to now, four generations of such polymers have been described. Of most interest are poly(ortho esters) III and poly(ortho est
Externí odkaz:
https://doaj.org/article/9e89c71a6d6944e79d42e504f703d7a3
Autor:
Jorge Heller, M. Savoldelli, Cyrus Tabatabay, R.A. Bejjani, François D'Hermies, Francine Behar-Cohen, Robert Gurny, Stéphanie Ponsart, Suzanne Einmahl
Publikováno v:
Journal of Biomedical Materials Research. :44-53
The biocompatibility of autocatalyzed poly(ortho ester) (POE70LA30), a viscous, hydrophobic, bioerodible polymer, was investigated. POE70LA30 was synthesized, sterilized by gamma irradiation, and injected in rabbit eyes at adequate volumes through su
Autor:
Suzanne Einmahl, Sergio Capancioni, Robert Gurny, Michael Moeller, Francine Behar-Cohen, K. Schwach-Abdellaoui
Publikováno v:
Advanced Drug Delivery Reviews, Vol. 53, No 1 (2001) pp. 45-73
Poly(ortho esters) (POE) are hydrophobic and bioerodible polymers that have been investigated for pharmaceutical use since the early 1970s. Among the four described generations of POE, the third (POE III) and fourth (POE IV) are promising viscous and
Publikováno v:
Macromolecular Symposia. 172:73-86
A poly(ortho ester) (POE) has been investigated as a carrier for controlled delivery in intraocular therapy. The intraocular biocompatibility of POE was assessed in the rabbit after intravitreal as well as suprachoroidal injections. In both cases, th
Autor:
Suzanne Einmahl, Robert Gurny, François D'Hermies, M. Savoldelli, Cyrus Tabatabay, Francine Behar-Cohen, J. Heller, D. Chauvaud
Publikováno v:
Journal of Biomedical Materials Research. 50:566-573
The biocompatibility of a viscous, hydrophobic, bioerodible poly(ortho ester) (POE) intended for intraocular application was investigated. POE was evaluated as a blank carrier and as containing modulators of degradation. Each formulation was injected
Autor:
J. Heller, James M. Anderson, Robert Gurny, Cyrus Tabatabay, Suzanne Einmahl, T. Le Minh, Monia Zignani
Publikováno v:
Biomaterials, Vol. 21, No 17 (2000) pp. 1773-1778
The poly(ortho ester), POE, used in this investigation, is a viscous bioerodible polymer (8 kDa), which rapidly degrades into a triol and an acidic by-product, acetic acid. In order to improve biocompatibility, we have evaluated the addition of vario
Autor:
Jean-Luc Veuthey, Emmanuel Varesio, Vincent Baeyens, Suzanne Einmahl, Robert Gurny, J. Heller, Cyrus Tabatabay, Monia Zignani, James M. Anderson
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, No 2 (2000) pp. 251-5
A viscous hydrophobic poly(ortho ester) (POE) has been developed as a biocompatible, biodegradable sustained release system for selected cases of glaucoma filtering surgery. Dexamethasone and 5-fluorouracil (5-FU) are frequently administered together
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a278422c0332d27b63e5aee605324698
https://archive-ouverte.unige.ch/unige:5068
https://archive-ouverte.unige.ch/unige:5068
Autor:
Emmanuel Varesio, Jean-Luc Veuthey, J. Heller, Cyrus Tabatabay, Suzanne Einmahl, Monia Zignani, Robert Gurny
Publikováno v:
International Journal of Pharmaceutics, Vol. 185, No 2 (1999) pp. 189-98
A viscous bioerodible and hydrophobic poly(ortho ester) has been developed as a biocompatible, sustained drug release system for an ophthalmic application in intraocular proliferative disorders. The combination of wound healing modulators such as 5-f
Autor:
Steve Ng, J. Heller, Alexandra Rothen-Weinhold, Suzanne Einmahl, Robert Gurny, K. Schwach-Abdellaoui, John Barr, H.-R. Shen
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 50:327